JP2023510870A5 - - Google Patents

Info

Publication number
JP2023510870A5
JP2023510870A5 JP2022542896A JP2022542896A JP2023510870A5 JP 2023510870 A5 JP2023510870 A5 JP 2023510870A5 JP 2022542896 A JP2022542896 A JP 2022542896A JP 2022542896 A JP2022542896 A JP 2022542896A JP 2023510870 A5 JP2023510870 A5 JP 2023510870A5
Authority
JP
Japan
Prior art keywords
human
seq
stat3
polypeptide
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022542896A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023510870A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/013519 external-priority patent/WO2021146485A2/en
Publication of JP2023510870A publication Critical patent/JP2023510870A/ja
Publication of JP2023510870A5 publication Critical patent/JP2023510870A5/ja
Priority to JP2025277551A priority Critical patent/JP2026053539A/ja
Pending legal-status Critical Current

Links

JP2022542896A 2020-01-14 2021-01-14 Icd statシグナル伝達が改変されたcd122 Pending JP2023510870A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025277551A JP2026053539A (ja) 2020-01-14 2025-12-23 Icd statシグナル伝達が改変されたcd122

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062961157P 2020-01-14 2020-01-14
US62/961,157 2020-01-14
PCT/US2021/013519 WO2021146485A2 (en) 2020-01-14 2021-01-14 Cd122 with altered icd stat signaling

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025277551A Division JP2026053539A (ja) 2020-01-14 2025-12-23 Icd statシグナル伝達が改変されたcd122

Publications (2)

Publication Number Publication Date
JP2023510870A JP2023510870A (ja) 2023-03-15
JP2023510870A5 true JP2023510870A5 (cg-RX-API-DMAC7.html) 2024-01-22

Family

ID=76863264

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022542896A Pending JP2023510870A (ja) 2020-01-14 2021-01-14 Icd statシグナル伝達が改変されたcd122
JP2025277551A Pending JP2026053539A (ja) 2020-01-14 2025-12-23 Icd statシグナル伝達が改変されたcd122

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025277551A Pending JP2026053539A (ja) 2020-01-14 2025-12-23 Icd statシグナル伝達が改変されたcd122

Country Status (10)

Country Link
US (1) US20230027899A1 (cg-RX-API-DMAC7.html)
EP (1) EP4090339A4 (cg-RX-API-DMAC7.html)
JP (2) JP2023510870A (cg-RX-API-DMAC7.html)
KR (1) KR20220131529A (cg-RX-API-DMAC7.html)
CN (1) CN115038453A (cg-RX-API-DMAC7.html)
AU (1) AU2021208559A1 (cg-RX-API-DMAC7.html)
CA (1) CA3165753A1 (cg-RX-API-DMAC7.html)
IL (1) IL293822A (cg-RX-API-DMAC7.html)
MX (1) MX2022008769A (cg-RX-API-DMAC7.html)
WO (1) WO2021146485A2 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102777151B1 (ko) 2017-11-21 2025-03-05 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 인터루킨-2의 부분 효능제
CN115362168A (zh) 2020-01-14 2022-11-18 辛德凯因股份有限公司 偏向化il2突变蛋白方法和组合物
JP2023520572A (ja) * 2020-04-06 2023-05-17 シンセカイン インコーポレイテッド オルソゴナルな受容体を発現するようにゲノムが改変されたヒト免疫細胞
CN121194988A (zh) * 2023-05-17 2025-12-23 北京晶泰科技有限公司 白细胞介素-2变体及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6832709B2 (ja) * 2014-05-16 2021-02-24 メディミューン,エルエルシー 新生児Fc受容体結合が改変されて治療および診断特性が強化された分子
CA2974998C (en) * 2015-02-12 2022-04-26 Takara Bio Inc. Chimeric antigen receptors
TWI833684B (zh) * 2015-06-25 2024-03-01 美商生物細胞基因治療有限公司 嵌合抗原受體(car)、組合物及其使用方法
JP7299021B2 (ja) * 2015-09-11 2023-06-27 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 生体関連の直交性サイトカイン/受容体ペア
WO2018035387A1 (en) * 2016-08-17 2018-02-22 The Broad Institute, Inc. Novel crispr enzymes and systems
US11648296B2 (en) * 2019-12-13 2023-05-16 Synthekine, Inc. IL-2 orthologs and methods of use
CN115315273A (zh) * 2020-01-14 2022-11-08 辛德凯因股份有限公司 Il-2直向同源物及其使用方法
WO2021207290A1 (en) * 2020-04-06 2021-10-14 Synthekine, Inc. Engineered immune cells
US20250382382A1 (en) * 2022-03-08 2025-12-18 Synthekine, Inc. Orthogonal gpc3 chimeric antigen receptor t cells

Similar Documents

Publication Publication Date Title
JP7556583B2 (ja) Kras突然変異を識別するt細胞受容体およびそのコード配列
JP2023506454A5 (cg-RX-API-DMAC7.html)
JP2023085527A5 (cg-RX-API-DMAC7.html)
JP7340127B2 (ja) がんに対する免疫療法で使用するための形質移入t細胞およびt細胞受容体
MX2022011411A (es) Proteinas de union a antigeno que se unen especificamente a mage-a.
JP2022017333A5 (cg-RX-API-DMAC7.html)
DK2443137T3 (en) NOVEL chemokine-binding peptides capable of impeding the sequence for immunity, inflammation and cancer
KR100924475B1 (ko) 결핵의 면역치료 및 진단용 화합물과 이의 사용 방법
Thole et al. Molecular and immunological analysis of a fibronectin‐binding protein antigen secreted by Mycobacterium leprae
RU2020133171A (ru) Биологически значимые ортогональные пары цитокинов/рецепторов
EA012507B1 (ru) Высокоаффинные мелан-а т-клеточные рецепторы
JP2021531834A5 (cg-RX-API-DMAC7.html)
TW202140540A (zh) 一種辨識hpv的t細胞受體
JP2021531834A (ja) Afp抗原を識別するt細胞受容体
JP2024513559A5 (cg-RX-API-DMAC7.html)
JP2009500298A5 (cg-RX-API-DMAC7.html)
JP2024514556A5 (cg-RX-API-DMAC7.html)
WO2021038031A1 (en) Tcr constructs specific for ebv-derived antigens
CN109608547B (zh) 表达Her2的嵌合抗原受体、慢病毒表达载体及其应用
AU2005298245B2 (en) A thymus-specific protein
TW202144399A (zh) 一種辨識hpv抗原的t細胞受體及其編碼序列
KR20240164594A (ko) 설계된 사이토카인 조성물 및 사용 방법
TW202144401A (zh) 一種辨識afp的t細胞受體
BRPI0517362A (pt) polipeptìdeo, molécula de ácido nucleico purificada, vetor, célula hospedeira, anticorpo, métodos in vitro para diagnosticar uma doença em um paciente, composição farmacêutica, composição de vacina, uso de um polipeptìdeo, proteina de fusão, e, método para produção de proteìna
TW202140532A (zh) 一種辨識afp的t細胞受體及其編碼序列